June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Inhibition of Multidrug-Resistant Pseudomonas aeruginosa with Rose Bengal Photodynamic Antimicrobial Therapy: In vitro
Author Affiliations & Notes
  • Felipe Echeverri Tribin
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Brandon Chou
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Katherine Krishna
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Heather Ann Durkee
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jorge Maestre
    Ocular Microbiology Laboratory, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Angel Suarez
    Ocular Microbiology Laboratory, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Maribel Hernandez
    Ocular Microbiology Laboratory, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Harry W Flynn, Jr
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Anne Bates Leach Eye Center, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Guillermo Amescua
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Anne Bates Leach Eye Center, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jean-Marie Parel
    Ophtalamic Biophysics Center, Department of Ophtalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Anne Bates Leach Eye Center, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Darlene Miller
    Ocular Microbiology Laboratory, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Anne Bates Leach Eye Center, Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Felipe Echeverri Tribin None; Brandon Chou None; Katherine Krishna None; Heather Durkee University of Miami, Code P (Patent); Jorge Maestre None; Angel Suarez None; Maribel Hernandez None; Harry Flynn, Jr None; Guillermo Amescua University of Miami, Code P (Patent); Jean-Marie Parel University of Miami, Code P (Patent); Darlene Miller University of Miami, Code P (Patent)
  • Footnotes
    Support  This work was financially supported in part by the Florida Lions Eye Bank and the Beauty of Sight Foundation, the Edward D. and Janet K. Robson Foundation, NIH Center Grant (P30EY14801), Research to Prevent Blindness – Unrestricted Grant to BPEI (GR004596), the Henri and Flore Lesieur Foundation (JMP), and donations from Drs. Harry W. Flynn Jr, Karl R. Olsen, Martha E. Hildebrandt, Raksha Urs, Aaron Furtado.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 606. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Felipe Echeverri Tribin, Brandon Chou, Katherine Krishna, Heather Ann Durkee, Jorge Maestre, Angel Suarez, Maribel Hernandez, Harry W Flynn, Jr, Guillermo Amescua, Jean-Marie Parel, Darlene Miller; Inhibition of Multidrug-Resistant Pseudomonas aeruginosa with Rose Bengal Photodynamic Antimicrobial Therapy: In vitro. Invest. Ophthalmol. Vis. Sci. 2023;64(8):606.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pseudomonas aeruginosa is the leading cause of gram-negative bacterial keratitis and has worse clinical prognosis than other forms of bacterial keratitis. Increased antibiotic resistance makes medical management of these infections challenging. One such example is multidrug-resistant (MDR) Pseudomonas aeruginosa which is resistant to the most common antimicrobials including: resistance to fluoroquinolones (ciprofloxacin, levofloxacin) aminoglycosides (amikacin, gentamicin, tobramycin), cephalosporins (ceftazidime, cefepime) and carbapenems (imipenem, meropenem). Novel therapies are needed to treat these challenging microorganisms. This study will measure the in vitro inhibitory effect of rose bengal photodynamic therapy against recent MDR Pseudomonas aeruginosa isolates from patients with infectious keratitis.

Methods : Five clinical MDR Pseudomonas aeruginosa isolates from patients with confirmed infectious keratitis were isolated and prepared into inoculum of concertation 10E8 CFU/mL. Three Groups were tested: control, 0.1% rose bengal dark, and 0.1% rose bengal green light. Inoculum suspension was mixed with either NaCL (control) or 0.1% rose bengal for a final organism concentration of 10E4 CFU/mL. 1mL aliquots were plated on blood agar plates in triplicate. Agar plates were divided by light condition and relevant groups were exposed to green light irradiation for 15 minutes with a custom-built green light LED array. At 48 hours, agar plates were photographed to measure bacterial growth inside of a centered 47-mm irradiation zone.

Results : Rose Bengal without green light had no impact on the growth of MDR Pseudomonas aeruginosa strains when compared to the control group. Rose Bengal with green light fully inhibited all MDR Pseudomonas aeruginosa strains inside the irradiation zone.

Conclusions : MDR Pseudomonas aeruginosa can be inhibited by rose bengal photodynamic antimicrobial therapy with 0.1% concentrations. The effectiveness of different exposure time, rose bengal concentration, and light energy were not explored but are warranted for further study. The use of rose bengal photodynamic therapy in MDR Pseudomonas is promising as an alternative to current treatments.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1. Growth inhibition results from RB PDAT. (Top) Control plates (Middle) RB without irradiation (Bottom) RB with irradiation.

Figure 1. Growth inhibition results from RB PDAT. (Top) Control plates (Middle) RB without irradiation (Bottom) RB with irradiation.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×